VBIV लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:55):
Our systems believe the stock currently is overvalued by -0.08% compare to its pairs and should correct downwards.

Stats
आज की मात्रा	69 175
औसत मात्रा	446 070
बाजार मूल्य	18.64M
EPS	$-0.730 ( Q1 \| 2024-05-15 )
अगली कमाई की तारीख	( $-0.320 ) 2024-08-12
Last Dividend	$0.250 ( 2012-04-02 )
Next Dividend	$0 ( N/A )
P/E	-0.180 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00100 (0.15%)

AADI -2.94%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 2.89%

ABUS -2.30%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.41%

ACGN 1.29%

ACHL -3.00%

ACHV -1.61%

ACIU -1.00%

ACLX 0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.10%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.40%

AKRO -2.81%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.21%

ALLK -9.32%

ALLO -5.87%

ALLR -3.22%

ALNA 3.16%

ALNY 1.95%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.65%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.09%

APLT -4.50%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.58%

ARGX -0.73%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.64%

ARWR -1.56%

ASLN -5.04%

ASMB -7.14%

ASND -0.94%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.90%

ATRA -2.93%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA 1.17%

AUTL -1.58%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.48%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.96%

BCAB 2.30%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.32%

BCTX 7.65%

BCTXW -16.29%

BCYC 1.10%

BDRX -3.52%

BDTX -0.43%

BEAM 0.49%

BFRA -2.91%

BGNE -2.72%

BIOR -3.40%

BIVI 2.05%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.71%

BMEA -9.88%

BMRN 0.38%

BNOX -2.22%

BNTC -2.11%

BNTX -1.47%

BOLD -8.11%

BOLT 1.31%

BPMC -1.21%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.88%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.35%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.17%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.16%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.07%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.96%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.54%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.02%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -7.50%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.08%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.82%

CORT 2.20%

COYA -1.46%

CPRX -0.99%

CRBP -1.88%

CRBU -4.83%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.81%

CRSP 0.93%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -1.35%

CTXR 2.03%

CUE 3.53%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.99%

CYTO -2.73%

DARE 6.41%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 34.01%

DNLI -1.43%

DNTH -6.02%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.98%

ELOX 7.69%

ELTX -0.88%

ELVN -4.05%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.57%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.24%

FATE -7.80%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.82%

FENC -0.97%

FGEN -5.56%

FHTX 2.10%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -2.36%

GLYC -10.00%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.92%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.83%

GOVX 7.27%

GOVXW -49.04%

GPCR -6.48%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.15%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.57%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.46%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.78%

ICCC 0.22%

ICPT 0.21%

ICU 16.49%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.94%

IFRX -1.85%

IGMS -0.15%

IKNA 0.30%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.68%

INAB 0.00%

INBX 0.53%

INCY -0.86%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 3.01%

INO -2.21%

INSM -0.85%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.42%

IONS 0.43%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.03%

JAZZ -0.74%

JNCE 0.00%

JSPR -6.10%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.85%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 18.60%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.46%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.05%

LPTX -1.10%

LQDA -0.33%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.44%

LYRA 2.33%

MACK 0.10%

MBIO -9.32%

MBRX -1.72%

MCRB 1.76%

MDGL -2.70%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.80%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.79%

MNKD -1.15%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.86%

MREO -5.29%

MRKR 2.68%

MRNA -4.81%

MRNS -4.04%

MRSN -2.61%

MRTX -0.17%

MRUS 0.13%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 6.78%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -1.32%

NMTR -42.97%

NOVN -24.84%

NRBO 12.08%

NRIX -0.34%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.22%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -2.48%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.21%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.28%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.34%

PDSB -2.52%

PEPG 0.27%

PGEN -3.04%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.28%

PTE -0.82%

PTGX -1.76%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.96%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.41%

RCKT -7.76%

REGN -0.70%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.51%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.44%

RIGL -3.29%

RLAY -4.68%

RLMD 0.33%

RLYB 0.00%

RNA -0.49%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX -0.06%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.20%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.46%

RYTM -6.51%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -3.88%

SAVA -0.31%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 0.00%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -3.00%

SNDX 0.87%

SNGX -4.52%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.44%

SRRA 0.00%

SRRK -2.79%

SRZN -2.45%

STAB 0.00%

STOK -5.09%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.29%

SWTX 0.34%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.57%

TARS -0.23%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.14%

TENX -1.27%

TERN -7.72%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.16%

TNXP -6.39%

TNYA -7.02%

TPST 2.87%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -2.79%

TTNP -9.27%

TVTX 0.63%

TYRA -7.01%

UBX -2.12%

UNCY -2.43%

URGN -1.00%

UTHR -0.39%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.55%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.54%

VIRI -1.57%

VIRX 2.40%

VKTX -1.67%

VLON -13.04%

VNDA -2.20%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.40%

VRPX 0.38%

VRTX 0.39%

VSTM -3.58%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.90%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.85%

XERS 2.38%

XFOR 2.62%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-07-27	Dewilde Michel	Buy	35 000	Option (Right to Buy Common Shares)
2023-07-27	Braga Damian	Buy	35 000	Option (Right to Buy Common Shares)
2023-07-27	Baxter Jeff	Buy	70 000	Option (Right to Buy Common Shares)
2023-07-27	Cordeiro Joanne	Buy	35 000	Option (Right to Buy Common Shares)
2023-07-27	Beattie Nell	Buy	52 500	Option (Right to Buy Common Shares)

INSIDER POWER
-68.01
Last 96 transactions
Buy: 56 847 323 \| Sell: 16 390 901

सहसंबंध (AI algo v.1.1b): Overvalued: -0.08% $0.651 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.10 (neutral)

छोटा: 0.77 (moderate)

Signal:(56.029) Neutral

VBI Vaccines Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

VBI Vaccines Inc सहसंबंध - मुद्रा/वस्त्र

0.00
( neutral )

-0.41
( neutral )

VBI Vaccines Inc वित्तीय

Annual	2023
राजस्व:	$8.68M
सकल लाभ:	$-5.82M (-66.98 %)
EPS:	$-5.96

FY	2023
राजस्व:	$8.68M
सकल लाभ:	$-5.82M (-66.98 %)
EPS:	$-5.96

FY	2022
राजस्व:	$1.08M
सकल लाभ:	$-10.19M (-942.14 %)
EPS:	$-16.37

FY	2021
राजस्व:	$631 000
सकल लाभ:	$-10.14M (-1 606.81 %)
EPS:	$-0.270

Financial Reports:

No articles found.

VBI Vaccines Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

VBI Vaccines Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.250	2003-12-18
Last Dividend	$0.250	2012-04-02
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	$1.250	--
Avg. Dividend % Per Year	0.00%	--
Score	0.23	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2027-05-31)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.23

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2003	$0.250	14.60%
2004	$0	0.00%
2005	$0	0.00%
2006	$0.750	16.50%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0.250	0.02%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
02 Apr 2012	$0.250	30 Nov -0001	30 Nov -0001	30 Nov -0001
12 Jan 2006	$0.750	30 Nov -0001	30 Nov -0001	30 Nov -0001
18 Dec 2003	$0.250	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.82	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-1.100	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-10.82	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.340	0.800	-3.30	-2.64	[1 - 3]
quickRatioTTM	0.185	0.800	-3.62	-2.90	[0.8 - 2.5]
cashRatioTTM	0.162	1.500	-0.209	-0.314	[0.2 - 2]
debtRatioTTM	0.672	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-99.66	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-2.04	2.00	-0.681	-1.362	[0 - 30]
freeCashFlowPerShareTTM	-2.06	2.00	-1.031	-2.06	[0 - 20]
debtEquityRatioTTM	-9.28	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	-0.291	1.000	-8.18	-8.18	[0.2 - 0.8]
operatingProfitMarginTTM	-7.56	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.991	1.000	-6.62	-6.62	[0.2 - 2]
assetTurnoverTTM	0.125	0.800	-2.50	-2.00	[0.5 - 2]
Total Score				-7.71

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.191	1.000	-0.120	0	[1 - 100]
returnOnEquityTTM	-10.82	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.06	2.00	-0.688	-2.06	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.04	2.00	-0.681	-1.362	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.00971	1.500	-3.40	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-5.34	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.80

VBI Vaccines Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

VBI Vaccines Inc

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.